233 related articles for article (PubMed ID: 18455739)
1. Memantine protects against amphetamine derivatives-induced neurotoxic damage in rodents.
Chipana C; Torres I; Camarasa J; Pubill D; Escubedo E
Neuropharmacology; 2008 Jun; 54(8):1254-63. PubMed ID: 18455739
[TBL] [Abstract][Full Text] [Related]
2. Memantine prevents MDMA-induced neurotoxicity.
Chipana C; Camarasa J; Pubill D; Escubedo E
Neurotoxicology; 2008 Jan; 29(1):179-83. PubMed ID: 17980434
[TBL] [Abstract][Full Text] [Related]
3. Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications.
Escubedo E; Camarasa J; Chipana C; García-Ratés S; Pubill D
Int Rev Neurobiol; 2009; 88():121-66. PubMed ID: 19897077
[TBL] [Abstract][Full Text] [Related]
4. Methyllycaconitine prevents methamphetamine-induced effects in mouse striatum: involvement of alpha7 nicotinic receptors.
Escubedo E; Chipana C; Pérez-Sánchez M; Camarasa J; Pubill D
J Pharmacol Exp Ther; 2005 Nov; 315(2):658-67. PubMed ID: 16076935
[TBL] [Abstract][Full Text] [Related]
5. Protection against MDMA-induced dopaminergic neurotoxicity in mice by methyllycaconitine: involvement of nicotinic receptors.
Chipana C; Camarasa J; Pubill D; Escubedo E
Neuropharmacology; 2006 Sep; 51(4):885-95. PubMed ID: 16901518
[TBL] [Abstract][Full Text] [Related]
6. Different oxidative profile and nicotinic receptor interaction of amphetamine and 3,4-methylenedioxy-methamphetamine.
Chipana C; García-Ratés S; Camarasa J; Pubill D; Escubedo E
Neurochem Int; 2008 Feb; 52(3):401-10. PubMed ID: 17716785
[TBL] [Abstract][Full Text] [Related]
7. Dopamine D2-receptor knockout mice are protected against dopaminergic neurotoxicity induced by methamphetamine or MDMA.
Granado N; Ares-Santos S; Oliva I; O'Shea E; Martin ED; Colado MI; Moratalla R
Neurobiol Dis; 2011 Jun; 42(3):391-403. PubMed ID: 21303698
[TBL] [Abstract][Full Text] [Related]
8. Memantine is a useful drug to prevent the spatial and non-spatial memory deficits induced by methamphetamine in rats.
Camarasa J; Rodrigo T; Pubill D; Escubedo E
Pharmacol Res; 2010 Nov; 62(5):450-6. PubMed ID: 20553881
[TBL] [Abstract][Full Text] [Related]
9. Methamphetamine and 3,4-methylenedioxymethamphetamine interact with central nicotinic receptors and induce their up-regulation.
Garcia-Ratés S; Camarasa J; Escubedo E; Pubill D
Toxicol Appl Pharmacol; 2007 Sep; 223(3):195-205. PubMed ID: 17614110
[TBL] [Abstract][Full Text] [Related]
10. Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity.
Pubill D; Canudas AM; Pallàs M; Camins A; Camarasa J; Escubedo E
Naunyn Schmiedebergs Arch Pharmacol; 2003 May; 367(5):490-9. PubMed ID: 12684743
[TBL] [Abstract][Full Text] [Related]
11. Free radical production induced by methamphetamine in rat striatal synaptosomes.
Pubill D; Chipana C; Camins A; Pallàs M; Camarasa J; Escubedo E
Toxicol Appl Pharmacol; 2005 Apr; 204(1):57-68. PubMed ID: 15781294
[TBL] [Abstract][Full Text] [Related]
12. Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
Hansen JP; Riddle EL; Sandoval V; Brown JM; Gibb JW; Hanson GR; Fleckenstein AE
J Pharmacol Exp Ther; 2002 Mar; 300(3):1093-100. PubMed ID: 11861820
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxicity of amphetamine derivatives is mediated by caspase pathway activation in rat cerebellar granule cells.
Jiménez A; Jordà EG; Verdaguer E; Pubill D; Sureda FX; Canudas AM; Escubedo E; Camarasa J; Camins A; Pallàs M
Toxicol Appl Pharmacol; 2004 Apr; 196(2):223-34. PubMed ID: 15081269
[TBL] [Abstract][Full Text] [Related]
14. 3,4-Methylenedioxy-methamphetamine induces in vivo regional up-regulation of central nicotinic receptors in rats and potentiates the regulatory effects of nicotine on these receptors.
Pubill D; Garcia-Ratés S; Camarasa J; Escubedo E
Neurotoxicology; 2013 Mar; 35():41-9. PubMed ID: 23261423
[TBL] [Abstract][Full Text] [Related]
15. Memantine prevents the cognitive impairment induced by 3,4-methylenedioxymethamphetamine in rats.
Camarasa J; Marimón JM; Rodrigo T; Escubedo E; Pubill D
Eur J Pharmacol; 2008 Jul; 589(1-3):132-9. PubMed ID: 18582864
[TBL] [Abstract][Full Text] [Related]
16. Comparative neurochemical profile of 3,4-methylenedioxymethamphetamine and its metabolite alpha-methyldopamine on key targets of MDMA neurotoxicity.
Escubedo E; Abad S; Torres I; Camarasa J; Pubill D
Neurochem Int; 2011 Jan; 58(1):92-101. PubMed ID: 21074589
[TBL] [Abstract][Full Text] [Related]
17. Memantine attenuates 3,4-methylenedioxymethamphetamine-induced hyperthermia in rats.
Nisijima K; Kuboshima K; Shioda K; Yoshino T; Iwamura T; Kato S
Neurosci Lett; 2012 Dec; 531(2):198-203. PubMed ID: 23142720
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of serotonin release by sustained exposure to MDMA and methamphetamine in rat organotypic mesencephalic slice cultures containing raphe serotonergic neurons.
Higuchi M; Suzuki Y; Yatani Y; Kitagawa Y; Nagayasu K; Shirakawa H; Nakagawa T; Kaneko S
J Neurochem; 2008 Sep; 106(6):2410-20. PubMed ID: 18662325
[TBL] [Abstract][Full Text] [Related]
19. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
Biezonski DK; Meyer JS
J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
[TBL] [Abstract][Full Text] [Related]
20. The effects of 3,4-methylenedioxymethamphetamine (MDMA) on nicotinic receptors: intracellular calcium increase, calpain/caspase 3 activation, and functional upregulation.
Garcia-Ratés S; Camarasa J; Sánchez-García AI; Gandía L; Escubedo E; Pubill D
Toxicol Appl Pharmacol; 2010 May; 244(3):344-53. PubMed ID: 20132834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
